Search Results - "TOI, M" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study

by Rugo, H.S., O’Shaughnessy, J., Boyle, F., Toi, M., Broom, R., Blancas, I., Gumus, M., Yamashita, T., Im, Y.-H., Rastogi, P., Zagouri, F., Song, C., Campone, M., San Antonio, B., Shahir, A., Hulstijn, M., Brown, J., Zimmermann, A., Wei, R., Johnston, S.R.D., Reinisch, M., Tolaney, S.M.
Published in Annals of oncology (01.06.2022)

Get full text

Journal Article

Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array

Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array

by Toi, M, Asao, Y, Matsumoto, Y, Sekiguchi, H, Yoshikawa, A, Takada, M, Kataoka, M, Endo, T, Kawaguchi-Sakita, N, Kawashima, M, Fakhrejahani, E, Kanao, S, Yamaga, I, Nakayama, Y, Tokiwa, M, Torii, M, Yagi, T, Sakurai, T, Togashi, K, Shiina, T
Published in Scientific reports (07.02.2017)

Get full text

Journal Article

Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis

Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis

by Matsumoto, Y, Asao, Y, Yoshikawa, A, Sekiguchi, H, Takada, M, Furu, M, Saito, S, Kataoka, M, Abe, H, Yagi, T, Togashi, K, Toi, M
Published in Scientific reports (15.01.2018)

Get full text

Journal Article

Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer

Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer

by Bell, R., Brown, J., Parmar, M., Toi, M., Suter, T., Steger, G.G., Pivot, X., Mackey, J., Jackisch, C., Dent, R., Hall, P., Xu, N., Morales, L., Provencher, L., Hegg, R., Vanlemmens, L., Kirsch, A., Schneeweiss, A., Masuda, N., Overkamp, F., Cameron, D.
Published in Annals of oncology (01.04.2017)

Get full text

Journal Article

Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3

Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3

by Goetz, M.P., Toi, M., Huober, J., Sohn, J., Trédan, O., Park, I.H., Campone, M., Chen, S.-C., Manso, L.M., Paluch-Shimon, S., Freedman, O.C., O’Shaughnessy, J., Pivot, X., Tolaney, S.M., Hurvitz, S.A., Llombart-Cussac, A., André, V., Saha, A., van Hal, G., Shahir, A., Iwata, H., Johnston, S.R.D.
Published in Annals of oncology (01.08.2024)

Get full text

Journal Article

Patritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer

Patritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer

by Suzuki, E., Kotake, T., Nishimura, T., Yamaguchi, A., Pu, F., Toi, M.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

12 epigenetic markers panel for circulating DNA in plasma in detection of early stage breast cancer

12 epigenetic markers panel for circulating DNA in plasma in detection of early stage breast cancer

by Uehiro, N, Sato, F, Saji, S, Toi, M
Published in European journal of cancer (1990) (01.06.2016)

Get full text

Journal Article

Alteration of circulating endothelial progenitor cell counts could be an independent predictive factor for response to neoadjuvant chemotherapy in patients with breast cancer

Alteration of circulating endothelial progenitor cell counts could be an independent predictive factor for response to neoadjuvant chemotherapy in patients with breast cancer

by Tanaka, S, Ueno, T, Ishiguro, H, Toi, M
Published in European journal of cancer (1990) (01.06.2016)

Get full text

Journal Article

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

by Masuda, N., Higaki, K., Takano, T., Matsunami, N., Morimoto, T., Ohtani, S., Mizutani, M., Miyamoto, T., Kuroi, K., Ohno, S., Morita, S., Toi, M.
Published in Cancer chemotherapy and pharmacology (01.08.2014)

Get full text

Journal Article

Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer

Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer

by Dewan, M.Z., Ahmed, S., Iwasaki, Y., Ohba, K., Toi, M., Yamamoto, N.
Published in Biomedicine & pharmacotherapy (01.07.2006)

Get full text

Journal Article Conference Proceeding

P292 Cell-free DNA (cfDNA) profiling using Guardant360 in Japanese metastatic breast cancer patients

P292 Cell-free DNA (cfDNA) profiling using Guardant360 in Japanese metastatic breast cancer patients

by Kawashima, M., Fujimoto, Y., Tsuji, W., Yotsumoto, F., Komi, Y., Suwa, H., Taji, T., Izumi, A., Torii, M., Matsutani, Y., Suzuki, E., Tokiwa, M., Kawaguchi-Sakita, N., Mori, Y., Yamaguchi, A., Kawaguchi, K., Takada, M., Toi, M.
Published in Breast (Edinburgh) (01.04.2023)

Get full text

Journal Article

The application of indocyanine green fluorescence navigation method to a sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer

The application of indocyanine green fluorescence navigation method to a sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer

by Yamagami, K., Matsumoto, H., Hashimoto, T., Yanai, S., Yuen, S., Yata, Y., Ichinose, Y., Deai, T., Toi, M.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes

P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes

by Johnston, S., Toi, M., O’Shaughnessy, J., Rastogi, P., Campone, M., Neven, P., Huang, C.S., Huober, J., Jaliffe, G. Garnica, Cicin, I., Tolaney, S., Goetz, M.P., Rugo, H., Senkus, E., Testa, L., Del Mastro, L., Shimizu, C., Wei, R., Shahir, A., Munoz, M., Antonio, B. San, Andre, V., Harbeck, N., Martín, M.
Published in Breast (Edinburgh) (01.04.2023)

Get full text

Journal Article

Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)

Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)

by Kawaguchi, H., Masuda, N., Nakayama, T., Aogi, K., Anan, K., Ito, Y., Ohtani, S., Sato, N., Saji, S., Tokunaga, E., Nakamura, S., Hasegawa, Y., Hattori, M., Fujisawa, T., Morita, S., Yamaguchi, M., Yamashita, T., Yamamoto, Y., Ohno, S., Toi, M.
Published in Breast cancer research and treatment (01.06.2017)

Get full text

Journal Article

Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial

Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial

by Masuda, N., Toi, M., Yamamoto, N., Iwata, H., Kuroi, K., Bando, H., Ohtani, S., Takano, T., Inoue, K., Yanagita, Y., Kasai, H., Morita, S., Sakurai, T., Ohno, S.
Published in Breast cancer (Tokyo, Japan) (01.07.2018)

Get full text

Journal Article

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

by Ohno, S., Chow, L. W. C., Sato, N., Masuda, N., Sasano, H., Takahashi, F., Bando, H., Iwata, H., Morimoto, T., Kamigaki, S., Nakayama, T., Nakamura, S., Kuroi, K., Aogi, K., Kashiwaba, M., Yamashita, H., Hisamatsu, K., Ito, Y., Yamamoto, Y., Ueno, T., Fakhrejahani, E., Yoshida, N., Toi, M.
Published in Breast cancer research and treatment (01.11.2013)

Get full text

Journal Article

Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer

Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer

by Kawaguchi, K, Suzuki, E, Yamamoto, M, Yamaguchi, A, Morita, S, Toi, M
Published in European journal of cancer (1990) (01.06.2016)

Get full text

Journal Article

Management of abemaciclib associated adverse events in patients with hormone receptor positive (HR+), HER2- advanced breast cancer: Analysis of the MONARCH trials

Management of abemaciclib associated adverse events in patients with hormone receptor positive (HR+), HER2- advanced breast cancer: Analysis of the MONARCH trials

by Rugo, H.S., Tolaney, S.M., Huober, J., Toi, M., André, V., Barriga, S., Forrester, T., Sledge, G.W., Goetz, M.P.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

Clinical efficacy of eribulin as first- or second-line treatment for patients with recurrent HER2-negative breast cancer: A phase II randomized study (JBCRG-19)

Clinical efficacy of eribulin as first- or second-line treatment for patients with recurrent HER2-negative breast cancer: A phase II randomized study (JBCRG-19)

by Watanabe, K.-I., Aogi, K., Kitada, M., Sangai, T., Ohtani, S., Aruga, T., Kawaguchi, H., Fujisawa, T., Maeda, S., Morimoto, T., Morita, S., Masuda, N., Toi, M., Ohno, S.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

The sequential use of endocrine treatment for advanced breast cancer: where are we?

The sequential use of endocrine treatment for advanced breast cancer: where are we?

by Barrios, C., Forbes, J.F., Jonat, W., Conte, P., Gradishar, W., Buzdar, A., Gelmon, K., Gnant, M., Bonneterre, J., Toi, M., Hudis, C., Robertson, J.F.R.
Published in Annals of oncology (01.06.2012)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[20]